Managing Director
CurrentNicholas Marshall & Associates Pty. Ltd. is a consultancy providing personalised service to companies / sponsors requiring assistance with feasibility and study start-up activities, regulatory and Australian quarantine issues, monitoring and other help setting up and undertaking clinical trials of drugs and medical devices in Australia, New Zealand. There is currently opportunity to assist sponsors in these activities on short or longer term contractual bases, working directly with sponsors through their specific company organizational structure as an ‘outlier’ or ‘field worker’ attending clinical study activities in Australia and New Zealand, thus providing a seamless integration with sponsor procedures. Proven experience in general study related activities as well as "rescue" work for clinical trials, including: PD-1 / PD L-1 inhibitor studies treating various cancersNon-small cell lung cancerMetastatic MelanomaIntractable pain (new drug and novel delivery device)Seven cardiology device studies (various sponsors / various devices)Endarterectomy deviceHeart valve replacement study (audit)Biventricular pacingCardiac resynchronisation therapy device (CRT-D)HIV vaccine (17 Thailand sites)Nutrition Gene TherapyInfluenza vaccine (novel administration device)DIC / Sepsis (Phase II ICU)Gynaecologic device studiesCardiac Ablation TherapyCervical Device studyVarious "secondment" / "in-house" positionsExperience with Medidata-RAVE, RAVE-X, INFORM, SILK et al / company specific e-CRFs and CTMS